益盛药业股价跌5.12%，诺安基金旗下1只基金位居十大流通股东，持有198.63万股浮亏损失83.42万元

Group 1 - Yisheng Pharmaceutical's stock price fell by 5.12% on November 21, closing at 7.79 yuan per share, with a trading volume of 51.63 million yuan and a turnover rate of 2.79%, resulting in a total market capitalization of 2.578 billion yuan [1] - The stock has experienced a continuous decline for four consecutive days, with a cumulative drop of 4.98% during this period [1] - Yisheng Pharmaceutical, established on June 11, 1997, and listed on March 18, 2011, specializes in the research, production, and sales of traditional Chinese medicine, with its main revenue sources being capsule products (47.89%), injection products (30.94%), cosmetics (7.39%), ginseng products (6.89%), other products (6.59%), and bee products (0.31%) [1] Group 2 - Among the top ten circulating shareholders of Yisheng Pharmaceutical, a fund under Nuoan Fund, specifically Nuoan Multi-Strategy Mixed A (320016), entered the top ten in the third quarter, holding 1.9863 million shares, which accounts for 0.86% of the circulating shares [2] - The estimated floating loss for the fund today is approximately 834,200 yuan, with a total floating loss of 854,100 yuan during the four-day decline [2] - Nuoan Multi-Strategy Mixed A was established on August 9, 2011, with a current scale of 1.855 billion yuan, achieving a year-to-date return of 73.37% and ranking 205 out of 8,136 in its category [2]